Disclosure Panels Details Page
B-Cell Lymphomas Panel - Disclosures as of 09/04/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Jeremy Abramson MD, MMSc | Celgene Corporation Juno Therapeutics, Inc. Seattle Genetics, Inc. |
AbbVie, Inc. Celgene Corporation EMD Serono Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Roche Laboratories, Inc. |
None | None | ✔ |
| Ranjana Advani MD | Agensys Celgene Forty Seven Genentech/Roche Genetech/Roche Janssen Pharmaceutical Kura Merck Millenium Pharmacyclics Regeneron Sanofi Seattle Genetics |
AstraZeneca Pharmaceuticals LP Bayer HealthCare Cell Medica Genentech/Roche Gilead Kite Pharma Kyowa Seattle Genetics Takeda |
None | None | ✔ |
| Nancy Bartlett MD | ADC Therapeutics Affimed Autolus Bristol-Myers Squibb Company Celgene Corporation Forty Seven, Inc. Genentech, Inc. Immune Design Janssen Pharmaceutica Products, LP Kite Pharma Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Pharmacyclics Seattle Genetics, Inc. |
ADC Therapeutics | None | None | ✔ |
| Paolo Caimi MD | ADC Therapeutics Genentech, Inc. Millennium Pharmaceuticals, Inc. OncoTartis Rhizen Pharmaceuticals Roche Laboratories, Inc. TG Therapeutics |
Fate Therapeutics Genentech, Inc. Kite Pharma |
Celgene Corporation | None | ✔ |
| Julie Chang MD | None | None | None | None | - |
| Julio Chavez MD | Bayer HealthCare Celgene Corporation Genentech, Inc. Karyopharm Therapeutics Kite Pharma Novartis Pharmaceuticals Corporation |
None | Janssen Pharmaceutica Products, LP | None | - |
| Beth Christian MD | Acerta Pharma Celgene Corporation Cephalon, Inc. Genentech, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Millennium Pharmaceuticals, Inc. MorphoSys AG Seattle Genetics, Inc. Triphase |
Genentech, Inc. Seattle Genetics, Inc. |
None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Bita Fakhri MD | None | None | None | None | - |
| Luis Fayad MD | None | None | None | None | ✔ |
| Martha Glenn MD | Genentech, Inc. | None | None | None | ✔ |
| Leo Gordon MD | Zylem (nanoparticle research) | Takeda Pharmaceuticals North America, Inc. | Bayer HealthCare Gilead Sciences, Inc. Juno Therapeutics, Inc. |
None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Thomas Habermann MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Laura Hanisch PsyD | None | None | None | None | ✔ |
| Nancy Lee Harris MD | None | None | None | None | - |
| Francisco Hernandez-Ilizaliturri MD | None | Celgene Corporation Karyopharm Therapeutics Kite Pharma Seattle Genetics |
Pharmacyclics | None | ✔ |
| Mark Kaminski MD | None | Nordic Nanovector | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | ✔ |
| Christopher Kelsey MD | Duke University Medical Center | None | None | None | ✔ |
| Nadia Khan MD | Bristol-Myers Squibb Company | Seattle Genetics, Inc. | Genentech, Inc. | None | ✔ |
| Susan Krivacic MPAff | None | None | None | None | - |
| Ann LaCasce MD, MMSc | None | Bristol-Myers Squibb Company Seattle Genetics, Inc. |
Research to Practice | None | - |
| Amitkumar Mehta MD | None | None | AstraZeneca Pharmaceuticals LP Celgene Corporation Kite Pharmaceuticals Kyowa Hakko Kirin Co., Ltd. Seattle Genetics, Inc. Spectrum Pharmaceuticals, Inc. |
None | ✔ |
| Auayporn Nademanee MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Rachel Rabinovitch MD | None | None | None | None | ✔ |
| Nishitha Reddy MD | None | AbbVie, Inc. Bayer HealthCare Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. |
Celgene Corporation | None | ✔ |
| Erin Reid MD | AbbVie, Inc. ADC Therapeutics Aptose Biosciences Millennium Pharmaceuticals, Inc. Xencor |
None | None | None | ✔ |
| Kenneth Roberts MD | None | None | None | None | ✔ |
| Stephen Smith MD | Acerta Pharma AstraZeneca Pharmaceuticals LP DeNovo Biopharma Genentech, Inc. Incyte Corporation Merck & Co., Inc. Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. |
AstraZeneca Pharmaceuticals LP | None | None | ✔ |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Bettyanne Sunderland BSN, RN, OCN | None | None | None | None | - |
| Jakub Svoboda MD | Bristol-Myers Squibb Company Celgene Corporation Incyte Corporation Merck & Co., Inc. Pharmacyclics Regeneron Pharmaceuticals, Inc. Seattle Genetics, Inc. TG Therapeutics |
AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Seattle Genetics, Inc. |
None | None | ✔ |
| Lode Swinnen MBChB | AbbVie, Inc. | Pharmacyclics | None | Johns Hopkins University | ✔ |
| Julie Vose MD, MBA | None | AbbVie, Inc. Acerta Pharma Epizyme Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Kite Pharma Novartis Pharmaceuticals Corporation Seattle Genetics, Inc. vaniam group |
Verastem | None | ✔ |
| Andrew Zelenetz MD, PhD | None | Adaptive Biotechnology Amgen Inc. AstraZeneca Pharmaceuticals LP Celgene Corporation Genentech, Inc. Gilead Hoffman La Roche MEI Pharma MorphoSys AG Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmacyclics Roche Laboratories, Inc. Versatem |
None | None | ✔ |